Mortality Risk for Patients with Cytomegalovirus Retinitis and Acquired Immune Deficiency Syndrome
Mortality Risk for Patients with Cytomegalovirus Retinitis and Acquired Immune Deficiency Syndrome
About this item
Full title
Author / Creator
Publisher
Chicago, IL: The University of Chicago Press
Journal title
Language
English
Formats
Publication information
Publisher
Chicago, IL: The University of Chicago Press
Subjects
More information
Scope and Contents
Contents
We prospectively followed up 589 patients to evaluate the relationship of anti-cytomegalovirus (CMV) treatment and immune reconstitution in response to highly active antiretroviral therapy (HAART) on the mortality risk of patients with CMV retinitis and acquired immune deficiency syndrome. The use of HAART was associated with an 81% lower mortality...
Alternative Titles
Full title
Mortality Risk for Patients with Cytomegalovirus Retinitis and Acquired Immune Deficiency Syndrome
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_71307191
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_71307191
Other Identifiers
ISSN
1058-4838
E-ISSN
1537-6591
DOI
10.1086/379077
